HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessment of the epidemiology and burden of measles in Southern Mozambique.

Abstract
Measles has been a major killer among vaccine-preventable diseases in children < 5 years of age in developing countries. Despite progress in global efforts to reduce mortality, measles remains a public health problem. Hospital-based measles surveillance was conducted in Manhica, Mozambique (July 2001-September 2004). Suspected cases and community-based controls were enrolled, and blood was collected for immunoglobulin M (IgM) confirmation. Two hundred fifty-three suspected cases and 477 controls were enrolled, with 85% (216 of 253) cases reported during a measles outbreak. Measles-IgM confirmation was 30% among suspected cases and 5% in controls. Fifty-eight percent (14 of 24) of laboratory-confirmed cases had records indicating previous measles vaccination. Mortality was 3% (8 of 246) among cases and 1% among controls (6 of 426). Forty-five percent (33 of 74) of cases were < 24 months of age and 22% occurred in infants < 9 months of age and were associated with a high case-fatality rate (25%). Our data suggest that improved diagnostics, new tools to protect infants < 9 months of age, and a supplemental dose of measles vaccine could assist measles control.
AuthorsInácio Mandomando, Denise Naniche, Marcela F Pasetti, Lilian Cuberos, Sergi Sanz, Xavier Vallès, Betuel Sigauque, Eusébio Macete, Delino Nhalungo, Karen L Kotloff, Myron M Levine, Pedro L Alonso
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 85 Issue 1 Pg. 146-51 (Jul 2011) ISSN: 1476-1645 [Electronic] United States
PMID21734140 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Measles Vaccine
Topics
  • Case-Control Studies
  • Disease Outbreaks
  • Humans
  • Measles (epidemiology, mortality, prevention & control)
  • Measles Vaccine (administration & dosage)
  • Mozambique (epidemiology)
  • Population Surveillance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: